VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Statistics

Total Valuation

VYNE has a market cap or net worth of $22.59 million. The enterprise value is -$2.34 million.

Market Cap	22.59M
Enterprise Value	-2.34M

Important Dates

The last earnings date was Friday, May 15, 2026, after market close.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

VYNE has 33.32 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	33.32M
Shares Outstanding	33.32M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	1.41%
Owned by Institutions (%)	37.00%
Float	30.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.76
Forward PS	27.68
PB Ratio	0.92
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.86

Current Ratio	20.86
Quick Ratio	20.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.16% and return on invested capital (ROIC) is -44.25%.

Return on Equity (ROE)	-63.16%
Return on Assets (ROA)	-37.01%
Return on Invested Capital (ROIC)	-44.25%
Return on Capital Employed (ROCE)	-98.91%
Weighted Average Cost of Capital (WACC)	15.25%
Revenue Per Employee	$45,400
Profits Per Employee	-$2.15M
Employee Count	10
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, VYNE has paid $4,000 in taxes.

Income Tax	4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.05% in the last 52 weeks. The beta is 2.00, so VYNE's price volatility has been higher than the market average.

Beta (5Y)	2.00
52-Week Price Change	-41.05%
50-Day Moving Average	0.63
200-Day Moving Average	0.49
Relative Strength Index (RSI)	65.66
Average Volume (20 Days)	237,800

Short Selling Information

The latest short interest is 120,676, so 0.36% of the outstanding shares have been sold short.

Short Interest	120,676
Short Previous Month	100,376
Short % of Shares Out	0.36%
Short % of Float	0.39%
Short Ratio (days to cover)	1.16

Income Statement

In the last 12 months, VYNE had revenue of $454,000 and -$21.46 million in losses. Loss per share was -$0.50.

Revenue	454,000
Gross Profit	454,000
Operating Income	-24.37M
Pretax Income	-21.71M
Net Income	-21.46M
EBITDA	-24.35M
EBIT	-24.37M
Loss Per Share	-$0.50

Balance Sheet

The company has $24.93 million in cash and n/a in debt, with a net cash position of $24.93 million or $0.75 per share.

Cash & Cash Equivalents	24.93M
Total Debt	n/a
Net Cash	24.93M
Net Cash Per Share	$0.75
Equity (Book Value)	24.64M
Book Value Per Share	0.74
Working Capital	24.55M

Cash Flow

Operating Cash Flow	-25.74M
Capital Expenditures	n/a
Depreciation & Amortization	23,000
Net Borrowing	n/a
Free Cash Flow	-25.74M
FCF Per Share	-$0.77

Margins

Gross Margin	100.00%
Operating Margin	-5,367.40%
Pretax Margin	-4,782.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VYNE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	-94.99%
FCF Yield	-113.96%

Analyst Forecast

The average price target for VYNE is $2.00, which is 195.03% higher than the current price. The consensus rating is "Buy".

Price Target	$2.00
Price Target Difference	195.03%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	111.65%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:18

Scores

Altman Z-Score	n/a
Piotroski F-Score	2